We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
-12.02%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.78B
AUM Growth
-$210M
(-11%)
Cap. Flow
+$95.4M
Cap. Flow
% of AUM
5.37%
Top 10 Holdings %
Top 10 Hldgs %
53.02%
Holding
70
New
17
Increased
15
Reduced
10
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$137M |
| 2 |
SRCL
Stericycle Inc
SRCL
|
+$108M |
| 3 |
Abbott
ABT
|
+$95.2M |
| 4 |
Pfizer
PFE
|
+$90.4M |
| 5 |
Eli Lilly
LLY
|
+$84.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$115M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$111M |
| 3 |
HCA Healthcare
HCA
|
+$68.6M |
| 4 |
Cigna
CI
|
+$52.6M |
| 5 |
Danaher
DHR
|
+$51.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.33% |
| 2 | Industrials | 6.08% |
| 3 | Financials | 4% |
| 4 | Real Estate | 0.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $129M | 7.27% |
475,000
+447,490
| +1,627% | +$137M |
|
2
Edwards Lifesciences
EW
$50B
| $110M | 6.2% |
4,650,000
-1,950,000
| -30% | -$47.1M |
|
|
SRCL
3
DELISTED
Stericycle Inc
SRCL
| $108M | 6.08% |
+775,000
| New | +$108M |
|
|
BCR
4
DELISTED
CR Bard Inc.
BCR
| $102M | 5.77% |
550,000
+75,000
| +16% | +$14.2M |
|
|
5
Abbott
ABT
$183B
| $90.5M | 5.09% |
2,250,000
+2,020,170
| +879% | +$95.2M |
|
|
6
Pfizer
PFE
$142B
| $84M | 4.73% |
+2,819,450
| New | +$90.4M |
|
|
7
Eli Lilly
LLY
$1.03T
| $83.7M | 4.71% |
+1,000,000
| New | +$84.4M |
|
|
RAD
8
DELISTED
Rite Aid Corporation
RAD
| $82.1M | 4.62% |
676,250
+76,250
| +13% | +$12.7M |
|
|
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
| $80.8M | 4.55% |
1,900,000
+500,000
| +36% | +$24.8M |
|
|
AET
10
DELISTED
Aetna Inc
AET
| $71.1M | 4% |
650,000
-175,000
| -21% | -$20.2M |
|
|
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
| $70.4M | 3.96% |
+450,000
| New | +$82.1M |
|
12
Vertex Pharmaceuticals
VRTX
$122B
| $67.7M | 3.81% |
650,000
+200,000
| +44% | +$25.7M |
|
|
AKRX
13
DELISTED
Akorn Inc
AKRX
| $66.3M | 3.73% |
2,325,000
+600,000
| +35% | +$24.8M |
|
14
Labcorp
LH
$25.9B
| $59.7M | 3.36% |
640,200
+232,800
| +57% | +$24.1M |
|
15
Universal Health Services
UHS
$9.88B
| $59.3M | 3.34% |
475,000
+460,100
| +3,088% | +$64M |
|
|
CVRS
16
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
| $53.9M | 3.03% |
19,981,655
| – | – |
|
17
McKesson
MCK
$101B
| $50.9M | 2.86% |
+275,000
| New | +$58.3M |
|
|
18
HCA Healthcare
HCA
$85.7B
| $44.5M | 2.5% |
575,000
-775,000
| -57% | -$68.6M |
|
19
Brookdale Senior Living
BKD
$3.49B
| $44.2M | 2.49% |
1,925,000
-925,000
| -32% | -$27.3M |
|
20
CALL
Agilent Technologies
A
$39.2B
| $34.3M | 1.93% |
+1,000,000
| New | +$37.8M |
|
|
21
CALL
Pfizer
PFE
$142B
| $31.4M | 1.77% |
+1,054,000
| New | +$33.8M |
|
|
TMH
22
DELISTED
Team Health Holdings Inc
TMH
| $24.3M | 1.37% |
+450,000
| New | +$28.1M |
|
23
Acadia Pharmaceuticals
ACAD
$4.55B
| $22.4M | 1.26% |
678,700
-146,300
| -18% | -$6.09M |
|
24
United Therapeutics
UTHR
$26.2B
| $22.4M | 1.26% |
+170,400
| New | +$27.3M |
|
25
Collegium Pharmaceutical
COLL
$1.17B
| $21M | 1.18% |
950,000
+476,336
| +101% | +$8.61M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q3 2015 Portfolio in Review
As of Q3 2015, HealthCor Management held 70 positions worth $1.78B, down 11% from $1.99B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
HealthCor Management deployed $95.4M of net new capital in Q3 2015, opening 17 new positions and adding to 15 existing holdings. Its largest new stake was Stericycle Inc: 775,000 shares worth $108M.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 60% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was HCA Healthcare, an estimated $68.6M trimmed.
- HealthCor Management's largest Q3 2015 buy was Stericycle Inc: 775,000 shares worth $108M.
- HealthCor Management added most to Allergan plc in Q3 2015, an estimated $137M increase.
- HealthCor Management's biggest Q3 2015 reduction was HCA Healthcare, cutting an estimated $68.6M.
- HealthCor Management fully exited MALLINCKRODT PUBLIC LIMITED COMPANY in Q3 2015, selling an estimated $115M.
- HealthCor Management's ten largest holdings make up 53% of its $1.78B portfolio in Q3 2015.
- HealthCor Management opened 17 new positions and closed 25 in Q3 2015.
- HealthCor Management's portfolio value fell 11% quarter-over-quarter to $1.78B.
Based on HealthCor Management's 13F filing for Q3 2015, filed 16 Nov 2015.